BACKGROUND/OBJECTIVE: The study was carried out to assess the relationship between nut consumption and lipid profile among Iranian adults. SUBJECT/METHODS: The study was based on data from the Isfahan Healthy Heart Program across three counties in central Iran in 2007. A cross-sectional survey of 9660 randomly selected adults aged X19 years were chosen based on sex, age and settlement distributions in each community. Nutritional behaviors were assessed by validated qualitative 48-item food frequency questionnaires, which covered regular intakes of four types of nuts: walnuts, almonds, pistachios and hazelnuts. Analysis of covariance and logistic regression tests were utilized to determine odds ratio (OR) 95% confidence interval of hyperlipidemia according to nut consumption patterns in unadjusted and three-adjusted models.
INTRODUCTION
Non-communicable diseases, particularly cardiovascular diseases rapidly increasing in developing countries, are the leading causes of disability and death worldwide. 1 To prevent or reduce the risk of cardiovascular diseases, the improvement of lipid profile via healthy nutrition has formed the core of diet-heart theory for several years. Nuts are nutrient-dense plant foods with a high total fat content of between 46 and 76%. They are the richest source of fat, mostly unsaturated fatty acids, after vegetable oil. 2 They also contain considerable amounts of plant sterols, antioxidant, dietary fiber, vitamins, minerals and phenolic compounds, but low amount of sodium. 3, 4 Unpeeled and unprocessed nuts have unique nutritive and non-nutritive bioactive molecules, most of which were separately shown to have beneficial effects on diverse cardiovascular disorders, including novel risk markers. 2, [5] [6] [7] Large epidemiologic studies have demonstrated that nuts, despite of their high fat and relatively energy-dense content, are beneficial in lipid profile modifications. [8] [9] [10] [11] [12] Four cohort studies discovered an average 37% risk reduction in death caused by coronary heart disease among those who consumed four or more servings of nuts each week, and an 8.3% reduction for those who ate nuts once weekly. 13 Although several studies investigated the effects of nut consumption on blood lipid levels, these studies differed in population, type, the pattern of nuts consumed, study design, sampling criteria and duration. This study examined the effects of four types of nuts commonly consumed by Iranians. Walnuts are mostly eaten for breakfast, while pistachios, almonds and hazelnuts are normally mixed together as snacks. This study was performed to assess the effects of nut consumption on the serum lipid levels of Iranian adults.
SUBJECTS AND METHODS Subjects
This study was based on collected data from the Isfahan Healthy Heart Program (IHHP) in 2007. IHHP was done in three counties in the central part of Iran. According to the 2000 National Census, the population was 1 895 856 in Isfahan, 275 084 in Najaf-Abad and 668 531 in Arak. 14, 15 Multistage random sampling was conducted to stratify the study populations according to the regional population distribution; a major final cross-sectional survey of 9660 randomly selected adults aged X19 years based on sex, age and settlement distributions in each community. Approximately 5-10% of households within these clusters were randomly selected. One individual aged X19 years per household was randomly selected if Iranian, mentally competent and not pregnant. Within households, single age-eligible subjects were selected at random from six specific age groups (19-24, 25-34, 35-44, 45-54 , 55-64 and 65-plus). Sampling was presented in details elsewhere. 14, 15 The study was approved by the Research Council of the Isfahan Cardiovascular Research Center (ICRC). Sampling details were presented elsewhere.
Data collection
Eligible individuals undertook a 30-min home interview by trained health professionals. The questionnaire included socioeconomic and demographic characteristics and dietary, smoking and physical activity behaviors.
14 Subjects' medical and drug history was obtained-in terms of dyslipidemia, diabetes and hypertension (HTN)-by well-trained physicians.
Dietary assessment
Common nuts consumed in Iran, including walnuts, almonds, pistachios and hazelnuts were assessed through two separate questions in a validated, 48-item food frequency questionnaire (FFQ). 16 The FFQ was adapted from the non-communicable disease intervention program questionnaire. 17 The question was open ended. Five nutrition experts did the facial and content validity. The FFQ precision was pre-tested among 200 adults aged 19-69 years, who were not the samples of the main study. They completed the questionnaire twice at a 2-week interval to assess test-retest reliability (r ¼ 0.8). Criterion validity was done by comparing three 24-h recall questionnaires. Although data are still under review and is yet to be published, the criterion validity was suitable for nuts consumption (r ¼ 0.51).
Measurements
Trained nurses obtained participants' blood samples by venipuncture from the left antecubital vein after 12-14 h of fasting. They kept all blood samples frozen at À 20 1C to be assayed within 72 h at the central laboratory of ICRC, which meets the criteria of the National Reference Laboratory (a WHOcollaborating center). Serum total cholesterol (TC) and triglycerides (TG) were determined by the standard enzymatic method using special kits (Immunodiagnostic, Frankfurt, Germany) in a Hitachi auto-analyzer (Hamburg-Eppendorf Hamburg, Germany). 18 High-density lipoprotein cholesterol (HDL-C) was measured enzymatically after precipitating the other lipoproteins with dextran sulfate magnesium chloride. Low-density lipoprotein cholesterol (LDL-C) was calculated using the Friedewald formula. Direct measurement of LDL-C was performed with a turbidimetric method for those with TG X400 mg/dl. 19 Abnormal serum lipid profiles were defined based on the National Cholesterol Education Panel Adult Treatment Panel III (NCEP-ATP III) as TC X240 mg/dl; TGs X200 mg/dl; HDL-C o40 mg/dl for males and o50 mg/dl for females; and LDL-C X160 mg/dl. 20 In addition, apoprotein (apo) A and apo B were measured by photometric method. Apo A p120 and apo B X125 mg/dl in all subjects, 21 apo B/apo A X0.9 in male and apo B/apo A X0.8 in female 22 were defined as risk factors. Anthropometric measurements were done by trained medical staff during the following standardized interview: weight was measured by scales, with minimum necessary clothing, and recorded to the nearest 0.5 kg. Height was measured in a standing position, without shoes to the nearest 0.5 cm using a no elastic meter, while shoulders were in a normal state. Body mass index (BMI) was calculated and recorded as weight in kilograms divided by height in square meters. 23 
Statistical analysis
Statistical analyses were performed using SPSS for Windows software (version 15; SPSS, Chicago, IL, USA). The significance level was set at Po0.05. Analysis of variance test was used to compare the means of basic characteristics based on the frequency of nut consumption (categorized as never, 1-3 times per week and 4 or more times per week). The prevalence of basic characteristics was calculated by w 2 test. Analysis of covariance test was applied to compare the means of lipid profiles according to the frequency of nut consumption by adjusting for age (19-24/25-34/ 35-44/45-54/55-64/65p), sex, BMI (o18.5/18.5-24.9/25-29.9/30-34.9/ 35-39.9/40p kg/m 2 ), smoking status (nonsmoker/current smoker), physical activity status (metabolic equivalent min per week), residency (urban/ rural), diabetes (yes/no), HTN (yes/no) family history of dyslipidemia (yes/ no), aspirin use, weekly intake of hydrogenated oil, unhydrogenated oil, butter, whole dairy products, fried foods, red meat, fruit and vegetables, consumption. The multilevel general linear mixed model was used to weigh the random effect of clusters. Dyslipidemic subjects were excluded from all analyses except the logistic regression test. Logistic regression model was utilized to determine unadjusted and three-adjusted models odds ratio (OR) 95% confidence interval (CI) of hyperlipidemia according to nut consumption patterns including model 1 with no adjustment; model 2 adjusted for sex and age groups; model 3 additionally adjusted for residency, BMI category, diabetes, HTN, aspirin use, family history of dyslipidemia, physical activity and smoking status. Multilevel generalized linear mixed model was applied to adjust random effect of clusters in model 4. Also this model additionally adjusted for consumption of hydrogenated oil, unhydrogenated oil, butter, whole dairy, fried food, red meat, fruit and vegetables.
Physical activity and all dietary components were modeled continuously. Participants who indicated little nut consumption (never/almost never) were considered as the reference category.
RESULTS
The mean frequency nut consumption was 2.4±2.1 per week, while 22% of population consumed nuts X4 times each week. The results revealed significant differences in the mean values of basic characteristics among three different nut consumption categories ( Table 1) . Regular consumption was most common among younger participants, males, non-diabetics, non-aspirin users, non-hypertensives, those with positive family history of dyslipidemia, lower BMI and hydrogenated oil consumption and more consumption of unhydrogenated oil, butter, whole dairy, fried food, red meat, fruit and vegetable and more physically active. Table 2 shows that higher nut consumption was significantly associated with lower TG, LDL-C, apo B/apo A ratio in both genders (all P-value o0.05). There were no significant relationships between frequent nut consumption and HDL-C, apo A and apo B levels in both genders, or TC levels in male subjects (all Pvalue o0.05). Table 3 illustrates the ORs and 95% CI for participants' dyslipidemia according to the frequency of nut consumption. In general, the frequency of nut consumption was inversely associated with dyslipidemia, especially for those who had consumed nuts X4 times a week. Crude ORs in participants who ate nuts X4 times each week compared with those who never/almost never ate nuts were 0.67 (0.57-0.79) for dyslipidemia, 0.62 (0.49-0.77) for hypercholesterolemia, 0.78 (0.64-0.94) for hypertriglyceridemia, 0.75 (0.64-0.87) for low HDL-C, 0.55 (0.44-0.69) for high LDL-C, 0.49 (0.29-0.82) for high apo B and 0.62 (0.53-0.74) for high apo B/apo A ratio, however it was non significant for low Apo A. When controlled for sex and age groups ORs increased enormously, however, in the multivariate 24 This study reveals that higher nut consumption is significantly associated with lower, TG, LDL-C and apo B/apo A in Iranian male and female subjects and lower TC only in Iranian females. Similarly, a systematic review of Mukuddem-Petersen et al., 25 published an overall decrease of 2-16% in TC and 2-19% in LDL-C concentration among those who consumed nuts in comparison with subjects on controlled diets. Moreover, a positive quality prospective cohort study showed identical results of nut consumption on lowering LDL-C, non-HDL-C, TC and apo B-100 concentrations in diabetic women. 26 In a randomized crossover trial, Rajaram et al., 27 concluded that a walnut diet could be even more efficient in lowering serum TC and LDL-C concentrations than a fish diet. The ratios of TC:HDL-C, LDL-C:HDL-C and apo B:apo A-I were also lower among those who consumed walnuts over controlled and fish diets. This study found no significant relationship between frequent nut intake and HDL-C as well as apo A levels in both genders. However, in a study by Sheridan et al., a 15% modification of the daily caloric intake with pistachios resulted in a significant increase in HDL-C. 28 The findings of a recently pooled analysis of 1284 observations from 25 clinical studies, performed with different nuts and conducted in seven different countries were consistent with our results showing no significant effects on or TG, except in participants with higher serum TG, in whom a significant reduction was observed. 29 In this study, more frequent nut consumption (4p times per week) of Iranians was markedly associated with lower lipid concentration in all four models. However, some models failed to reveal positive effects on low apo A and high LDL-C. Evidence supports the idea that the lipid-lowering effects of nuts are dose related, in similar gender, across all age groups and independent of the types of nuts tested. 25 We only surveyed a combination of four kinds of nuts, but recent studies have shown light on the specific indications of nuts individually. In one systematic review and meta-analysis, Banel and Hu found that diets supplemented with walnuts resulted in a notable reduction in TC and LDL-C but no effects on TG and HDL-C levels. 30 One small randomised clinical trial reported that an inclusion of 42.5 g walnuts per 2400 kcal may result in a significant decrease in TC, LDL-C levels, however, they failed to find any significant changes in ratios of TC:HDL-C, LDL-C:HDL-C and apo B:apo A-I in those who followed the walnut diet. 27 Although results on walnuts are controversial, a meta-analysis of randomized trials could not support that almond ingestion is solely beneficial for chasing lipid-modifying effects. 31 On the contrary, Sheridan et al, in a randomized crossover trial, illustrated that a daily substitution of high-fat snacks with two to three ounces of pistachios, over a 4-week period, resulted in a significant reduction in TC/HDL-C, LDL-C/HDL-C and HDL-C. 28 A 4-week randomized crossover trail by Gebauer et al., 32 reported a dose-dependent response on TC, HDL-C, LDL-C:HDL-C and non-HDL-C:HDL-C in subjects who consumed an iso-caloric diet with either 10 or 20% of total energy from pistachio nuts. Hazelnut-enriched diets have also been found to lower VLDL-C, TG and apo B concentrations and to raise HDL-C concentrations. However, no changes were observed in apo A-1 concentration between the control and hazelnut-enriched diets. 33 Tey et al. also proposed that the ingestion of three different forms of hazelnuts (ground, sliced or whole) could equally improve the lipoprotein profile of participants; thus they could be incorporated into the usual diet as a means of cardiovascular disease risk reduction. 34 There are several purported reasons, which indirectly may explain the biological plausibility of nut consumption and lipid profile improvements. 35, 36 First, the lipid content of nuts may not be highly bioaccessible meaning that a high proportion of this Relationship between nut consumption and lipid profile G Askari et al fat is excreted through feces. 37, 38 Second, the crunchy textural property of nuts promotes satiety, as the mechanical act of mastication results in the secretion of appetitive hormones such as cholecystokinin; that is, dietary compensation that finally leads to lower calorie and fat intakes. 39, 40 Third, as the decrease in LDL-C by nut diets is greater than predicted in most studies, it is proposed that nut constituents other than fatty acids, such as dietary fiber, minerals (for example, copper, magnesium and potassium), vitamins (for example, folic acid, niacin, vitamin E and vitamin B6), plant protein (for example, arginine), phenolic antioxidants and phytosterols are also bioactive in lowering serum TC. 41, 42 Recent evidence suggests that phytosterols in nuts interfere with cholesterol absorption because of their hydrophobicity, which is higher than cholesterol because of a bulkier hydrocarbon molecule, and entails a higher affinity for micelles than cholesterol. Consequently, cholesterol is displaced from micelles, limiting the amount available for absorption. 43, 44 Nuts are also rich sources of proteins, often with high L-arginine content. 44 L-arginine usually is prescribed as a supplement in individuals with high cholesterol levels. Nuts are also excellent sources of antioxidant vitamins (for example, tocopherols) and phenolic compounds. They provide a significant antioxidant load, 41, 45 and antiatherogenic effects. 46 The strengths of this study are that the large sample size consisted of participants with various socioeconomic and demographic characteristics, random sampling from three counties in central Iran, and control over a wide variety of potential confounders. Furthermore, the information was assessed through accredited and validated questionnaires.
Limitations
Limitations included the study's cross-sectional design, which is theoretically unable to clarify the effective factors resulting in nuts' lipid improvement properties. Causality can therefore not be demonstrated. Furthermore, our analyses could only make associations at a particular point in time and not take into account dietary changes over time. Our data supported an association between total nut consumption and lower dyslipidemia occurrences, but more studies are needed to establish the kind of nuts responsible for lowering lipids, and their individual degree of protection and effectiveness. The FFQ was qualitative, therefore it is impossible to assess nuts intake as gram or serving as well as energy intake. Our estimation may outline a missing dose responsible of nut consumption for different genders and various age groups. This information is specifically insufficient on the association of nut consumption and HDL-C concentration.
CONCLUSIONS
We concluded that frequent nut consumption, particularly X4 times a week, may reduce lipid concentrations and may exert cardio-protective effects among Iranians. However, more randomized clinical trials are required to illustrate the dose-response effect of nuts on lipid profile. Relationship between nut consumption and lipid profile G Askari et al
